David R Epstein Senti Biosciences, Inc. (SNTI) insider trading activity

SNTI Quotes by TradingView

David R Epstein is Director of Senti Biosciences, Inc.. Currently has a direct ownership of 123,252 shares of SNTI, which is worth approximately $269,921. The most recent transaction as insider was on Jun 08, 2022, when has been sold 112,519 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
0% 3M change
0% 12M change
Total Value Held $269,921

David R Epstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2022
BUY
Grant, award, or other acquisition
-
112,519 Added 47.72%
123,252 Common Stock

Also insider at

EVLO
Evelo Biosciences, Inc. Healthcare
Director
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
Director
RUBY
Rubius Therapeutics, Inc. Healthcare
Director
AXLA
Axcella Health Inc. Healthcare
Director
SGEN
Seagen Inc. Healthcare
CEO
TEM
Tempus AI, Inc.
DRE

David R Epstein

Director
South San Francisco, CA

Track Institutional and Insider Activities on SNTI

Follow Senti Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNTI shares.

Notify only if

Insider Trading

Get notified when an Senti Biosciences, Inc. insider buys or sells SNTI shares.

Notify only if

News

Receive news related to Senti Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNTI